Millions of individuals around the world experience symptoms of erectile dysfunction (ED). But, for how common ED is, it can ...

Hims & Hers Health ( HIMS 6.30%) is coming off a fantastic year in 2024 when its share price skyrocketed 172%. The telehealth ...

The millennial-focused digital health company Hims & Hers (HIMS) has donated $1 million to President-elect Donald Trump’s ...

Exclusive: Hims & Hers debuts chewables for erectile dysfunction For a company that was founded to eradicate stigmas around health issues, an ED-focused chewable is right on brand. Hims & Hers ...

Yet Hims & Hers is still up nearly 200% over the past 12 months. The company has made headlines for selling compounded versions of GLP-1 agonists, the popular diabetes and weight loss drugs ...

given the role of GLP-1 drugs in weight loss and diabetes treatment. Ongoing shortages of similar medications and regulatory updates could continue to affect market perspectives. HIMS Price Action ...